Viewing Study NCT04460066


Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2025-12-25 @ 2:06 PM
Study NCT ID: NCT04460066
Status: UNKNOWN
Last Update Posted: 2022-05-04
First Post: 2020-07-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.
Sponsor: Lee's Pharmaceutical Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module